Opening book details…
About this Medicine article
P1.18-01 RELAY EU/US Subset: Ramucirumab Plus Erlotinib Improves Progression-Free Survival in First-Line EGFR Mutation-Positive NSCLC by Aix, S.; Novello, S.; Garon, E.; Nakagawa, K.; Nadal, E.; Moro-Sibilot, D.; Garcia, M. Alonso; Fabre, E.; Frimodt-Moller, B.; Zimmermann, A.; Visseren-Grul, C.; Reck, M. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Aix, S.; Novello, S.; Garon, E.; Nakagawa, K.; Nadal, E.; Moro-Sibilot, D.; Garcia, M. Alonso; Fabre, E.; Frimodt-Moller, B.; Zimmermann, A.; Visseren-Grul, C.; Reck, M.
- Publisher
- Elsevier ; Elsevier Inc.; Elsevier BV (ISSN 1556-1380)
- Published
- 2019
- Field
- Medicine (Health Sciences)